SciSparc: Subsidiary NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration with Clearmind Covering LSD, Ketamine and Ibogaine Combinations

Stock Information for SciSparc Ltd.

Loading

Please wait while we load your information from QuoteMedia.